Karydakis Flap Versus Burow's Triangle Advancement Flap in the Surgery of Sacrococcygeal Pilonidal Sinus Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05289297 |
Recruitment Status :
Recruiting
First Posted : March 21, 2022
Last Update Posted : September 28, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pilonidal Sinus Sacrococcygeal Pilonidal Disease | Procedure: Karydakis Flap Procedure Procedure: Burow's Triangle Advancement Flap Procedure | Not Applicable |
Pilonidal sinus disease (PSD) is a chronic and inflammatory disease that is often generated in the sacrococcygeal region. It is commonly observed in puberty and young adult period and usually affects men. The incidence of pilonidal sinus disease is 26:100,000 and rising globally.
PSD risk factors contain young age, obesity, male gender, Mediterranean ethnicity, deep natal cleft, hairiness, and poor hygiene. It has been shown that PSD incidence increases in parallel with body weight. The precise etiology of pilonidal sinus disease is unclear. Many conservative and surgical methods have been described in treating pilonidal sinus disease. After the sinus area is excised, excision with laying open (secondary healing), excision with primary closure, marsupialization, and various flap techniques can be applied in surgical treatment. The primary principle in treatment is to ensure that the patient returns to normal life as soon as possible and eliminate recurrences. Although the best surgical technique in treating pilonidal sinus is controversial, the ideal operation should be cost-effective, simple to perform, short hospital stay, and have a low recurrence and complication rates. There is no definite consensus on an ideal technique yet.
In this study, we aim to compare the Karydakis flap and Burow's Triangle Advancement Flap techniques applied in the surgical treatment of pilonidal sinus in our clinic in terms of complications (wound dehiscence, seroma, hematoma, surgical site infection), time to return to normal activity, and recurrence.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 80 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Karydakis Flap Procedure Versus Burow's Triangle Advancement Flap Procedure in the Surgical Treatment of Sacrococcygeal Pilonidal Sinus Disease |
Actual Study Start Date : | June 12, 2022 |
Estimated Primary Completion Date : | June 1, 2024 |
Estimated Study Completion Date : | December 1, 2024 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Karydakis Flap Procedure
Vertical eccentric elliptical incision down to the post-sacral fascia, complete removal of unhealthy tissue, and normal tissue around the cyst and sinus tracts. Mobilization of the medial wound edge and advancement of the skin. Flap along the midline to the post-sacral fascia and suturing its margin to the lateral wound margin.
|
Procedure: Karydakis Flap Procedure
Pilonidal sinus surgery will be performed with the Karydakis Flap procedure. |
Active Comparator: Burow's Triangle Advancement Flap Procedure
The flap is incised along the base of the wedge-shaped defect, and a small Burow's triangle is excised on the opposite side. The skin is mobilized and shifted in the direction of the arrow to close the defect. Excising the small Burow's triangle eliminates a dog ear at the base of the flap.
|
Procedure: Burow's Triangle Advancement Flap Procedure
Pilonidal sinus surgery will be performed with the Burow's Triangle Advancement Flap procedure. |
- Pain score according to the visual analogue scale [ Time Frame: 1-3 days ]Postoperative pain after surgery ( measured by the visual analog score with 1 being minimum score and 10 being maximum score)
- Postoperative wound healing time [ Time Frame: 4 to 6 weeks ]Number of weeks of complete duration epithelialization of the wound
- Procedure-related complications [ Time Frame: 1 to 6 weeks ]Number of complications; related to the surgery, Type (wound dehiscence, seroma, hematoma, surgical site infection)
- Time to return to normal activity [ Time Frame: 4 to 6 weeks ]The number of weeks it passes the patient to return to normal activity.
- Recurrence of Pilonidal Sinus [ Time Frame: 6 - 12 months ]Number of patients with recurrence pilonidal disease
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients between the ages of 18-65
- Primary pilonidal sinus disease
- No abscess and absence of active infection during the operation
Exclusion Criteria:
- Patients under the age of 18 and over the age of 65
- Recurrent pilonidal sinus cases
- Patients with chronic comorbidities such as immunosuppression, collagen tissue disease, insulin-dependent diabetes mellitus, and neurological disease
- Patients with an ASA score of 3-4
- Patients with a body mass index greater than 35 kg/m2
- Patients with drug and alcohol addiction
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05289297
Contact: Muhammer Ergenç, MD | 902165642400 ext 1321 | muhammerergenc@gmail.com |
Turkey | |
Istanbul Sultanbeyli State Hospital | Recruiting |
Istanbul, Turkey, 34935 | |
Contact: Muhammer Ergenç, MD |
Principal Investigator: | Muhammer Ergenç, MD | Istanbul Sultanbeyli State Hospital |
Responsible Party: | Istanbul Sultanbeyli State Hospital |
ClinicalTrials.gov Identifier: | NCT05289297 |
Other Study ID Numbers: |
2022s01 |
First Posted: | March 21, 2022 Key Record Dates |
Last Update Posted: | September 28, 2023 |
Last Verified: | September 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Karydakis Flap Pilonidal Cyst |
Pilonidal Sinus Paranasal Sinus Diseases Cysts Neoplasms |
Nose Diseases Respiratory Tract Diseases Otorhinolaryngologic Diseases |